|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Pindolol#How Supplied]] |
| {{Pindolol}}
| |
| {{CMG}}
| |
| | |
| ==How Supplied==
| |
| | |
| Visken® (pindolol) tablets, USP
| |
| | |
| White, uncoated, heart-shaped tablets; 5 mg and 10 mg, packages of 100. 5 mg tablets engraved “VISKEN 5’’ on one side, and embossed “V’’ on other side (NDC 0078-0111-05). 10 mg tablets engraved “VISKEN 10’’ on one side, and embossed “V’’ on other side (NDC 0078-0073-05).
| |
| | |
| ====Store and Dispense====
| |
| | |
| Below 86°F (30°C); tight, light-resistant container.
| |
| | |
| ====Manufactured by:====
| |
| | |
| Novartis Pharmaceuticals Canada Inc.
| |
| Dorval (Quebec) Canada H9R 4P5
| |
| | |
| ====Distributed by:====
| |
| | |
| Novartis Pharmaceuticals Corporation
| |
| East Hanover, New Jersey 07936<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = VISKEN (PINDOLOL) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07fe9cc3-1ef2-420c-b45d-7f1e894b6ef9 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Beta blockers]]
| |
| [[Category:Drugs]]
| |